Mortality and pituitary disease

Annales d'Endocrinologie

Volumn 73, Issue 2, 2012, Pages 81-82

  Stewart, Paul M ^a   Sherlock, Mark ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; CANCER CONTROL; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CUSHING DISEASE; DISEASE ASSOCIATION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE DEFICIENCY; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS TUMOR; PITUITARY HORMONE DEFICIENCY; STANDARDIZED MORTALITY RATIO;

CAUSE OF DEATH; COMORBIDITY; HUMANS; MORTALITY; PITUITARY ACTH HYPERSECRETION; PITUITARY DISEASES; VASCULAR DISEASES;

EID: 84860920781     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2012.03.026     Document Type: Article

References (13)

1. Sherlock M., Ayuk J., Tomlinson J.W., Toogood A.A., Aragon-Alonso A., Sheppard M.C., et al. Mortality in patients with pituitary disease. Endocr Rev 2010, 31(3):301-342.
2. Ayuk J., Clayton R.N., Holder G., Sheppard M.C., Stewart P.M., Bates A.S. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 2004, 89:1613-1617.
3. Holdaway I.M., Bolland M.J., Gamble G.D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 2008, 159:89-95.
4. Etxabe J., Vazquez J.A. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994, 40:479-484.
5. Dekkers O.M., Biermasz N.R., Pereira A.M., Roelfsema F., van Aken M.O., Voormolen J.H., et al. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for non-functioning pituitary macroadenoma. J Clin Endocrinol Metab 2007, 92:976-981.
6. Colao A., Pivonello R., Spiezia S., Faggiano A., Ferone D., Filippella M., et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999, 84:2664-2672.
7. Rosén T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990, 336:285-288.
8. Tomlinson J.W., Holden N., Hills R.K., Wheatley K., Clayton R.N., Bates A.S., et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001, 357:425-431.
9. Bülow B., Hagmar L., Mikoczy Z., Nordström C.H., Erfurth E.M. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf) 1997, 46:75-81.
10. Sherlock M., Reulen R.C., Alonso A.A., Ayuk J., Clayton R.N., Sheppard M.C., et al. ACTH deficiency, higher doses of hydrocortisone replacement and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 2009, 94:4216-4223.
11. Bengtsson B.A., Abs R., Bennmarker H., Monson J.P., Feldt-Rasmussen U., Hernberg-Stahl E., et al. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. J Clin Endocrinol Metab 1999, 84:3929-3935.
12. Colao A., di Somma C., Cuocolo A., Spinelli L., Tedesco N., Pivonello R., et al. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 2001, 86:1874-1881.
13. Bülow B., Attewell R., Hagmar L., Malmström P., Nordström C.H., Erfurth E.M. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab 1998, 83:3897-3904.